NASDAQ:RETA
Delisted

Reta Stock Signals

etoro logo Buy RETA
*Your capital is at risk
$172.36
+0 (+0%)
At Close: Dec 22, 2023

Latest Data & Signals Issued

Below are some of the latest signals issued for RETA

General

Signal Type Signal Value Data
Score 0.000 125 days ( -74.40 %
Last Price $172.36 0 %
Performance History
7 Days
$172.36 $172.36
0%
30 Days
$172.36 $172.36
0%
12 Mos
$36.38 $172.36
373.78%

4/18

Active Buy Signals

Specific Signals

Short Term
Net score: 15.54
Signal Type Signal Value Importance Data
High / Low N/A Very Low $172.36 - $172.36
Trend - 3 mos 0 % High Width: 0 %
Pred. range - 3 mos N/A - N/A Low -100.00 % - -100.00 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Buy Very Low Dec 21, 2023 - 2 days
RSI Short Pivot Signal Sell Very Low Oct 05, 2023 - 56 days
Short MA 3 mos Sell Low Nov 30, -0001 - N/A days
Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days
Short/Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 46.06
Signal Type Signal Value Importance Data
Trend - 12 mos 248.60 % Very High Width: 37.01 %
Pred. range - 12 mos $574.85 - $787.60 High 233.52 % - 356.95 %
Short MA 12 mos Sell Very High Jul 25, 2023 - 107 days
Long MA 12 mos Buy Very High Feb 28, 2023 - 208 days
Short/Long MA 12 mos Sell Very High Nov 30, -0001 - N/A days
Pivot Long Sell Low Dec 21, 2023 - 2 days
RSI Long Pivot Signal Sell Low Oct 16, 2023 - 49 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT RETA
RETA
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney disease (CKD) caused by Alport syndrome, as well as for a form of pulmonary arterial hypertension associated ...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.39% Jun 10
E
ETD
$20.67
4.79% Jun 05
EAT
$140.46
16.94% Jun 05
TPR
$140.47
7.16% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE